Latest Comments

NeuPSIG 2017: three strategies for improving treatment options for neuropathic pain

NeuPSIG 2017: three strategies for improving treatment options for neuropathic pain

A 10-Year Race: Antibody Biosimilars Versus “Other” Biosimilars

A 10-Year Race: Antibody Biosimilars Versus “Other” Biosimilars

Will acne be the next indication to benefit from biologics?

Will acne be the next indication to benefit from biologics?

The Three-Pronged Strategy to Combat NASH

The Three-Pronged Strategy to Combat NASH

New Data Released for Roche’s Latest Game-Changing Drug for Multiple Sclerosis

New Data Released for Roche’s Latest Game-Changing Drug for Multiple Sclerosis

CRISPR: are genetic mutants the future of disease treatment?

CRISPR: are genetic mutants the future of disease treatment?